1. Treatment

    Comments Leave a Comment

    1-15 of 465 1 2 3 4 ... 29 30 31 »
    1. Mentioned In 465 Articles

    2. A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

      A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy
      ... prompting for a search of novel therapeutic options. Here, we aimed at repurposing FDA-approved drugs for NB treatment by performing a high-content screening of a 349 anticancer compounds library. ...
      Read Full Article
      Mentions: Treatment
    3. Children with neuroblastoma have an elevated risk of long-term psychological difficulties

      ...euroblastoma patients are doing in terms of psychological and educational outcomes. Before recent advances in treatment, this survivor population was much smaller and we were not able to analyse these sorts of long-term ...
      Read Full Article
      Mentions: Treatment
    4. Rigorous study finds widely used treatment for infection fails young cancer patients

      Rigorous study finds widely used treatment for infection fails young cancer patients
      ...ed bloodstream infections. The patients were randomly assigned to the same six-month schedule of central line treatment with either 70 percent ethanol solution or saline solution. About 44 percent of patients in both gro...
      Read Full Article
      Mentions: Treatment
    5. NCI-MATCH precision medicine clinical trial releases new findings, strengthens path forward for targeted cancer therapies

      NCI-MATCH precision medicine clinical trial releases new findings, strengthens path forward for targeted cancer therapies
      ...ymphoma, or myeloma that have progressed on standard treatment or rare cancers for which there is no standard treatment. A goal of the study was for about 25 percent of patients in the trial to have rare cancers. Surpris...
      Read Full Article
    6. 1-15 of 465 1 2 3 4 ... 29 30 31 »
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Drug Development, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Quotes about Treatment

    1. Until this legal action, parents were forced to accept the treatment they were offered in the randomised trial – even if the alternative treatment might offer better prospects for their child.
      In Court rules in favor of UK child seeking antibody treatment
    2. This transformational gift from the Haworth family provides funding for vital services and infrastructure to take pediatric cancer treatment to an entirely new level.
      In Endowment Gift Establishes Haworth Family Pediatric Oncology Innovative Therapeutics Clinic at Helen DeVos Children’s Hospital
    3. This new research shows that simple blood biomarkers can help identify at diagnosis a group of children with stage four neuroblastoma for whom new kinds of treatment are urgently needed.
      In Simple blood test could improve treatment for deadly childhood cancer